Alonso I, Garcia F, Valdes Tresanco M, Arrebola Sanchez Y, Ojeda Del Sol D, Sanchez Ramirez B
Mar Drugs. 2023; 21(5).
PMID: 37233473
PMC: 10221039.
DOI: 10.3390/md21050279.
Santaniello G, Nebbioso A, Altucci L, Conte M
Mar Drugs. 2023; 21(1).
PMID: 36662197
PMC: 9862894.
DOI: 10.3390/md21010024.
Taufa T, Subramani R, Northcote P, Keyzers R
Molecules. 2021; 26(15).
PMID: 34361690
PMC: 8347048.
DOI: 10.3390/molecules26154534.
Conte M, Fontana E, Nebbioso A, Altucci L
Mar Drugs. 2021; 19(1).
PMID: 33396307
PMC: 7824531.
DOI: 10.3390/md19010015.
Jing Q, Hu X, Ma Y, Mu J, Liu W, Xu F
Mar Drugs. 2019; 17(7).
PMID: 31252563
PMC: 6669562.
DOI: 10.3390/md17070384.
Natural Products Mediated Targeting of Virally Infected Cancer.
Fatima I, Kanwal S, Mahmood T
Dose Response. 2019; 17(1):1559325818813227.
PMID: 30670935
PMC: 6328957.
DOI: 10.1177/1559325818813227.
Anticancer Activity of Natural Compounds from Plant and Marine Environment.
Lichota A, Gwozdzinski K
Int J Mol Sci. 2018; 19(11).
PMID: 30423952
PMC: 6275022.
DOI: 10.3390/ijms19113533.
The Methylation Status of the Epigenome: Its Emerging Role in the Regulation of Tumor Angiogenesis and Tumor Growth, and Potential for Drug Targeting.
Pirola L, Ciesielski O, Balcerczyk A
Cancers (Basel). 2018; 10(8).
PMID: 30103412
PMC: 6115976.
DOI: 10.3390/cancers10080268.
Marine-derived angiogenesis inhibitors for cancer therapy.
Wang Y, Miao Z
Mar Drugs. 2013; 11(3):903-33.
PMID: 23502698
PMC: 3705379.
DOI: 10.3390/md11030903.
Psammaplin A inhibits hepatitis C virus NS3 helicase.
Salam K, Furuta A, Noda N, Tsuneda S, Sekiguchi Y, Yamashita A
J Nat Med. 2013; 67(4):765-72.
PMID: 23359228
DOI: 10.1007/s11418-013-0742-7.
In vitro evaluation of natural marine sponge collagen as a scaffold for bone tissue engineering.
Lin Z, Solomon K, Zhang X, Pavlos N, Abel T, Willers C
Int J Biol Sci. 2011; 7(7):968-77.
PMID: 21850206
PMC: 3157271.
DOI: 10.7150/ijbs.7.968.
Metalloproteinase inhibitors: status and scope from marine organisms.
Thomas N, Kim S
Biochem Res Int. 2011; 2010:845975.
PMID: 21197102
PMC: 3004377.
DOI: 10.1155/2010/845975.
Synthesis of the marine bromotyrosine psammaplin F and crystal structure of a psammaplin A analogue.
Yang Q, Liu D, Sun D, Yang S, Hu G, Wu Z
Molecules. 2010; 15(12):8784-95.
PMID: 21127464
PMC: 6259465.
DOI: 10.3390/molecules15128784.
Activity screening and structure-activity relationship of the hit compounds targeting APN/CD13.
Wang X, Jing F, Zhu H, Fang H, Zhang J, Xu W
Fundam Clin Pharmacol. 2010; 25(2):217-28.
PMID: 20636366
PMC: 7164084.
DOI: 10.1111/j.1472-8206.2010.00844.x.
Identification of a novel small molecule HIF-1alpha translation inhibitor.
Narita T, Yin S, Gelin C, Moreno C, Yepes M, Nicolaou K
Clin Cancer Res. 2009; 15(19):6128-36.
PMID: 19789328
PMC: 2770235.
DOI: 10.1158/1078-0432.CCR-08-3180.
Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.
Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H
Bioorg Med Chem. 2009; 17(13):4666-73.
PMID: 19454370
PMC: 7125801.
DOI: 10.1016/j.bmc.2009.04.056.
Induction of apoptosis in endometrial cancer cells by psammaplysene A involves FOXO1.
Berry E, Hardt J, Clardy J, Lurain J, Kim J
Gynecol Oncol. 2008; 112(2):331-6.
PMID: 19041124
PMC: 2662924.
DOI: 10.1016/j.ygyno.2008.10.017.
Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.
Bauvois B, Dauzonne D
Med Res Rev. 2005; 26(1):88-130.
PMID: 16216010
PMC: 7168514.
DOI: 10.1002/med.20044.
The marine bromotyrosine derivatives.
Peng J, Li J, Hamann M
Alkaloids Chem Biol. 2005; 61:59-262.
PMID: 16173400
PMC: 4943341.
DOI: 10.1016/s1099-4831(05)61002-4.